CIK 0001776985 · Large accelerated filer
BioNTech SE
Sign in to watch- Ticker
- BNTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Germany
- Entity type
- other
- Phone
- 0049613190840
- Business address
- AN DER GOLDGRUBE 12, MAINZ, Germany, 55131
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 4 Planned sale Chief Operating Officer sold 50,000 shares at $110.56 ($5,527,960)
- 3/A Insider 3/A
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F/A Report Annual and Transition Report of Foreign Private Issuers
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 30 · 590 filings